Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Treatment of peri-implantitis using platelet-rich fibrin

Official title: Surgical Treatment of Peri-implantitis With Adjunctive Application of Platelet Rich Fibrin (PRF) Compared With Open Flap Debridement (OFD) Alone: A 12-month Randomised Clinical Trial

Run by University of Bern · NCT06679283 · Data updated 2026-11-12

This study is testing whether adding platelet-rich fibrin to surgery can help people with peri-implantitis heal better and improve bone growth around their dental implants.

More Peri-implantitis trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorUniversity of Bern
Academic / other
Drugs / interventionsprednisone
Locations1 site (Bern)
StatusRecruiting
StartedFebruary 1, 2025
Main results expectedDecember 1, 2026
Study endsDecember 31, 2027
Registry record updatedMarch 30, 2026
Trial IDNCT06679283 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults with peri-implantitis characterized by specific clinical and radiographic criteria.

Probably not a fit

Patients with severe systemic diseases, chronic inflammatory conditions, or those who smoke more than five cigarettes may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of platelet-rich fibrin (PRF) in enhancing the surgical treatment of peri-implantitis, a condition characterized by inflammation and bone loss around dental implants. Participants will undergo open flap debridement either with the adjunctive application of PRF or without it, allowing for a comparison of outcomes. The study aims to assess improvements in bone regeneration and healing in patients with peri-implantitis defects. By evaluating the impact of PRF on treatment outcomes, the research seeks to provide evidence for its use in clinical practice.

Why it matters

Potential benefit: If successful, this approach could lead to improved healing and regeneration in patients suffering from peri-implantitis, potentially reducing the need for more invasive treatments.

How similar studies have gone: While some studies have shown positive effects of PRF in bone regeneration, evidence specifically for its use in peri-implantitis remains limited, making this approach somewhat novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. One or more peri-implant sites with PPD ≧ 5 mm combined with BOP/suppuration and
2. Peri-implant marginal bone loss, defined as a crater like defect ≧ 3 mm as assessed from intraoral radiographs
3. Good oral hygiene i.e. a plaque index \<20%
4. Written informed consent

Exclusion Criteria:

1. History of chronic inflammatory disease
2. Severe systemic diseases
3. Medically confirmed diagnosis of diabetes mellitus
4. Anti-inflammatory prescription including prednisone
5. Smoking \> 5 cigarettes
6. Pregnant or lactating women
7. \< 18 years of age

Where it's running

  • Department of Periodontology, University of Bern
    Bern, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.